Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
CRISPR/Cas9 gene editing has made possible a multitude of biomedical experiments including studies that systematically turn off genes in cancer cells to look for ones that the cancer cells heavily ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology CRISPR to treat cancer. In a study published in Nature, scientists recruited 16 people who ...
CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...
The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to new findings. The ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
(a) Utilizing HCR and CRISPR-Cas12a double amplification technique, a highly sensitive apta-HCR-CRISPR method was devised for the detection of TEV protein. (b) A novel CRISPR-Cas12a/Cas13a approach, ...
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who... CRISPR gene-editing may boost cancer immunotherapy, ...
Katie Pope Kopp, 64, of Parkville, Mo., at Union Station in Kansas City this week. Kopp underwent a new form of experimental CAR T-cell therapy that used the CRISPR gene-editing technique to treat her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results